STRATMANN Ansgar | Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

スポンサーリンク

概要

• STRATMANN Ansgarの詳細を見る
• 同名の論文著者
• Novartis Pharma AG, Research, Drug Discovery Center and Central Technologiesの論文著者

関連著者

• SCHUPP Thomas

  Novartis Pharma AG, Research Department

• OBERER Lukas

  Novartis Pharma Inc., Research, Department of Core Technology

• SCHILLING Wolfgang

  Novartis Pharma Inc., Research, Department of Core Technology

• Schilling Wolfgang

  Novartis Pharma Inc. Research Departments Of Core Technology And Transplantation

• Oberer Lukas

  Novartis Pharma Ag Research Deparment

• Oberer Lukas

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

• Schupp T

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

• Schupp Thomas

  Novartis Pharma Ag Research Department

• STRATMANN Ansgar

  Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

• TOUPET Christiane

  Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

• TRABER Rene

  Novartis Pharma AG, Research, Drug Discovery Center and Central Technologies

• Traber Rene

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

• Stratmann Ansgar

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

• Toupet Christiane

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

• Schilling Wolfgang

  Novartis Pharma Ag Research Drug Discovery Center And Central Technologies

もっと見る 閉じる

著作論文

• New Insights Rifamycin B Biosynthesis : Isolation of Proansamycin B and 34a-Deoxy-rifamycin W as Early Macrocyclic Intermediates Indicating Two Separated Biosynthetic Pathways

スポンサーリンク